The approval of revakinagene taroretcel (Encelto; Neurotech) addresses a significant unmet need for patients with macular ...
Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback